Audio Version: Press Play to Listen
Edinburgh, Scotland (August 13th, 2024) - Blackford, the pioneering AI platform and solutions provider, and 4DMedical company, Imbio, a leader in respiratory health imaging biomarkers, announce a commercial partnership to bring Imbio’s solutions to healthcare professionals via the Blackford Platform.
Blackford’s experienced team and tried-and-tested AI Platform enables healthcare providers to access an extensive portfolio of more than 135 AI solutions designed to drive clinical accuracy and efficiency and improve patient outcomes. By integrating Imbio’s advanced technology into the Blackford Platform, Blackford can offer healthcare providers more powerful tools to support the analysis of chest CT scans.
"We are delighted to join forces with Imbio, and integrate their wide range of chest CT solutions.” says Ben Panter, Founder and CEO of Blackford. “By incorporating Imbio's expertise into our portfolio, we are reinforcing our commitment to enhance diagnostic accuracy and patient care.”
Imbio products, including Lung Density Analysis™ and RV/LV Analysis™, utilize advanced AI algorithms for in-depth analysis of medical images. These offerings are essential for diagnosing and managing a variety of conditions with greater efficacy. Imbio technologies offer precise, reproducible assessments that impact treatment planning and patient outcomes. By leveraging sophisticated texture mapping algorithms and segmentation techniques, Imbio enhances the detection and monitoring of diseases such as Chronic Obstructive Pulmonary Disease (COPD), fibrosis, interstitial lung disease (ILD), and lung cancer.
“We are incredibly excited to be partnering with Blackford” said 4DMedical CEO and Founder, Andreas Fouras. “Imbio is committed to enhance diagnostic accuracy and optimized treatment strategies to help improve patient care worldwide. This partnership positions our Imbio products with a comprehensive distribution network across the leading platforms connecting AI providers with hospitals, doctors and their patients.”